3911 studies found for:
Lung Diseases, Obstructive
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 |
Completed
Has Results |
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
|
||||
| 22 | Completed |
Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
|
||||
| 23 |
Completed
Has Results |
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
|
||||
| 24 |
Completed
Has Results |
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
|
||||
| 25 |
Completed
Has Results |
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
||||
| 26 | Completed |
Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 27 | Recruiting |
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
|
||||
| 28 | Completed |
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 29 |
Completed
Has Results |
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 30 | Completed |
To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 31 | Completed |
A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 32 |
Completed
Has Results |
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 33 | Enrolling by invitation |
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 34 | Not yet recruiting |
Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease
|
||||
| 35 | Completed |
Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
|
||||
| 36 | Recruiting |
Role of Fibrocytes in Chronic Obstructive Pulmonary Disease
|
||||
| 37 | Unknown † |
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
||||
| 38 |
Completed
Has Results |
Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients
|
||||
| 39 | Completed |
Does Positive Expiratory Pressure Mask Therapy Improve Recovery From Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
|
||||
| 40 |
Completed
Has Results |
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
|
† Indicates status has not been verified in more than two years

